Institute for Molecular Medicine Finland, HiLIFE
Institute for Molecular Medicine Finland, HiLIFE

Building a bridge from discovery to medicine

OUR MISSION: FIMM is a translational institute with a driving mission to perform innovative research on patients and populations - utilizing molecular, genomic and health data – targeted towards understanding drivers of health and disease and delivering improvements to the safety, efficacy and efficiency of healthcare in Finland and beyond.

COVID-19 Research

Insights into how to better understand and treat COVID-19 are desperately needed. This page summarizes the FIMM efforts in contributing our researchers' expertise, technology and time to help to beat the COVID-19 pandemic.

FIMM on Twitter

Follow FIMM on Twitter for real-time news updates!

On July 12th we'll chat about what we can do about covid as scientists and as people.…

We are thrilled to announce the release of the ICDA Recommendations and White Paper! THANK YOU to the international……

More SARS-CoV-2 sequences from Finland are now available in Gisaid - a subset in Nextstrain. @GISAID…